KU
Cipla Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Lanreotide Injection | Neuroendocrine Tumors | Commercial |
| Biosimilar Bevacizumab | Various Cancers | Commercial |
| Biosimilar Trastuzumab | Breast Cancer | Commercial |
| Albuterol HFA | Asthma/COPD | Commercial |
| Generic Advair Equivalent | Asthma/COPD | Phase 3 |
| Biosimilar Rituximab | Lymphoma/Leukemia | Commercial |
| Glatiramer Acetate | Multiple Sclerosis | Commercial |